KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Change in Acquisitions & Divestments (2018 - 2023)

Esperion Therapeutics' Change in Acquisitions & Divestments history spans 5 years, with the latest figure at $17.5 million for Q2 2023.

  • For Q2 2023, Change in Acquisitions & Divestments rose 250.0% year-over-year to $17.5 million; the TTM value through Mar 2024 reached $17.5 million, down 81.18%, while the annual FY2023 figure was $42.5 million, 37.5% down from the prior year.
  • Change in Acquisitions & Divestments reached $17.5 million in Q2 2023 per ESPR's latest filing, down from $25.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $45.9 million in Q1 2019 to a low of $2.2 million in Q3 2020.
  • Average Change in Acquisitions & Divestments over 4 years is $20.8 million, with a median of $23.3 million recorded in 2019.
  • Peak YoY movement for Change in Acquisitions & Divestments: crashed 89.62% in 2020, then surged 250.0% in 2023.
  • A 4-year view of Change in Acquisitions & Divestments shows it stood at $5.0 million in 2019, then plummeted by 55.0% to $2.2 million in 2020, then skyrocketed by 1233.38% to $30.0 million in 2022, then plummeted by 41.67% to $17.5 million in 2023.
  • Per Business Quant, the three most recent readings for ESPR's Change in Acquisitions & Divestments are $17.5 million (Q2 2023), $25.0 million (Q1 2023), and $30.0 million (Q4 2022).